PRF Technologies (PRFX) EBIT (2020 - 2024)
PRF Technologies' (PRFX) quarterly EBIT came in at -$7.3 million in Q2 2024, down 226.15% YoY from $5.8 million in Q3 2023, and down 31.99% on a QoQ basis from -$5.6 million in Q1 2024.
PRF Technologies (PRFX) EBIT (2020 - 2024) Analysis & Trends
PRF Technologies (PRFX) has 5 years of EBIT data on file, last reported at -$7.3 million in Q2 2024.
- Quarterly EBIT fell 226.15% year-over-year to -$7.3 million in Q2 2024, while the trailing twelve-month figure through Jun 2024 was -$17.8 million (down 77.9% YoY) and the FY2025 annual result came in at -$5.1 million, up 65.09% from the prior year.
- EBIT slipped to -$7.3 million in Q2 2024, from -$5.6 million in the prior quarter.
- In the past five years, EBIT ranged from a high of -$132000.0 in Q1 2020 to a low of -$7.3 million in Q2 2024.
- A 5-year average of -$2.2 million and a median of -$1.8 million in 2021 frame the typical range for EBIT.
- Annual changes were most pronounced in 2021 — EBIT slumped 1444.7% — and 2023, when it surged 35.5%.
- Tracing PRFX's EBIT over 5 years: stood at -$691000.0 in 2020, then plunged by 151.95% to -$1.7 million in 2021, then slumped by 87.02% to -$3.3 million in 2022, then decreased by 9.46% to -$3.6 million in 2023, then sank by 106.09% to -$7.3 million in 2024.
- The last three EBIT figures came in at -$7.3 million (Q2 2024), -$5.6 million (Q1 2024), and -$3.6 million (Q4 2023), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.85 Bn | 42.88 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.02 Bn | 39.37 Bn | 2.15 Bn | -231.00 Mn |
| 3 | Zoetis | 31.47 Bn | 29.79 Bn | 1.05 Bn | 837.00 Mn |
| 4 | Takeda Pharmaceutical | 28.59 Bn | 22.79 Bn | 5.10 Bn | 1.26 Bn |
| 5 | United Therapeutics | 22.20 Bn | 19.53 Bn | 683.80 Mn | 330.80 Mn |
| 6 | Viatris | 18.76 Bn | 17.87 Bn | 1.46 Bn | 6.30 Mn |
| 7 | Neurocrine Biosciences | 15.45 Bn | 15.06 Bn | 935.80 Mn | 151.50 Mn |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn | 248.00 Mn |
| 9 | Dr Reddys Laboratories | 10.10 Bn | 9.94 Bn | - | - |
| 10 | PRF Technologies | 654,452.72 | -3.49 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2024 | -7.35 Mn |
| Mar 31, 2024 | -5.57 Mn |
| Dec 31, 2023 | -3.56 Mn |
| Sep 30, 2023 | -1.35 Mn |
| Jun 30, 2023 | -2.25 Mn |
| Mar 31, 2023 | -2.42 Mn |
| Dec 31, 2022 | -3.26 Mn |
| Sep 30, 2022 | -2.10 Mn |
| Jun 30, 2022 | -1.85 Mn |
| Mar 31, 2022 | -1.67 Mn |
| Dec 31, 2021 | -1.74 Mn |
| Sep 30, 2021 | -1.77 Mn |
| Jun 30, 2021 | -1.66 Mn |
| Mar 31, 2021 | -2.04 Mn |
| Dec 31, 2020 | -691,000.00 |
| Sep 30, 2020 | -700,000.00 |
| Jun 30, 2020 | -148,000.00 |
| Mar 31, 2020 | -132,000.00 |